(S (NP (NP (CD One)) (PP (IN of) (NP (NP (DT the) (JJ notable) (NNS features)) (PP (IN of) (NP (JJ undone) (NN science) (NNS debates)))))) (VP (VBZ is) (SBAR (WHADVP (WRB how)) (S (NP (NP (NN formation)) (PP (IN of) (NP (JJ new) (NN interest) (NNS groups)))) (VP (VBZ becomes) (ADJP (JJ pivotal) (PP (IN in) (S (VP (VBG mobilizing) (CC and) (VBG championing) (NP (NP (VBG emerging) (NN research)) (PP (IN on) (NP (JJ undone) (NNS topics)))))))))))) (. .))
(S (ADVP (NNP Clearly)) (NP (NN money)) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ important)) (NNS mediums)) (SBAR (WHPP (IN through) (WHNP (WDT which))) (S (NP (NP (JJ different) (NNS types)) (PP (IN of) (NP (NNS actors)))) (VP (MD can) (VP (VP (VB support)) (CC and) (VB steer) (S (NP (NNS scientists)) (VP (TO to) (VP (VB work) (PP (IN on) (NP (JJ undone) (NNS topics)))))))))))))) (. .))
(S (CC Yet) (SBAR (WHNP (WDT which) (NNS actors)) (S (VP (VBP are) (ADJP (RBR more) (JJ visible) (PP (IN in) (NP (NP (PRP$ their) (NN support)) (PP (IN for) (NP (JJ scientific) (NN research))))))))) (VP (VBZ is) (NP (NP (NN something)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB seldom)) (VP (VBN been) (VP (VBN measured)))))))) (. .))
(S (NP (DT This) (NN study)) (VP (VBZ delves) (PP (IN into) (NP (NN research) (NN funding))) (PP (IN in) (NP (NP (DT the) (NN context)) (PP (IN of) (NP (NP (JJ rare) (NNS diseases) (NN research)) (, ,) (NP (NP (DT a) (NN topic)) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (VP (VBN evolved) (PP (IN from) (NP (NP (DT the) (NNS margins)) (PP (IN of) (NP (JJ medical) (NN research))))) (PP (IN into) (NP (NP (DT a) (NN priority) (NN area)) (VP (VBN articulated) (PP (IN by) (NP (JJ many) (JJ contemporary) (NN funding) (NNS agencies)))))))))))))))) (. .))
(S (NP (JJ Rare) (VBZ diseases)) (VP (VBP refer) (PP (TO to) (NP (NP (NNS conditions)) (VP (VBG affecting) (NP (NP (ADJP (RB relatively) (JJ few)) (NNS people)) (PP (IN in) (NP (DT a) (NN population)))))))) (. .))
(S (PP (VBN Given) (NP (JJ low) (NNS incidences))) (, ,) (NP (NN interest) (NNS groups)) (VP (VBP have) (VP (VBN articulated) (NP (NP (DT a) (NN lack)) (PP (IN of) (NP (NN attention))) (PP (IN within) (NP (JJ medical) (NN research))) (PP (VBN compared) (PP (TO to) (NP (ADJP (RBR more) (JJ common)) (NNS conditions))))))) (. .))
(S (NP (NP (DT The) (NN rise)) (PP (TO to) (NP (NP (NN prominence)) (PP (IN of) (NP (JJ rare) (NNS diseases))) (PP (IN in) (NP (NN research) (NN funding) (NNS policies)))))) (VP (VP (VP (VBZ is) (ADVP (RB often)) (VP (VBN explained) (PP (IN in) (NP (DT the) (NN science) (NNS studies) (VBP literature))) (PP (IN in) (NP (NP (NNS terms)) (PP (IN of) (NP (NP (JJ effective) (NN lobbying)) (PP (IN by) (NP (JJ social) (NNS movements))))))))) (ADVP (NNP Likewise))) (, ,) (NP (NP (JJ innovative) (NN fundraising) (NNS initiatives)) (, ,) (NP (NN infrastructure) (NN building)) (, ,) (CC and) (NP (NP (RB close) (NNS partnerships)) (PP (IN with) (NP (NN research) (NNS groups))))) (VP (VBP are) (NP (NP (JJ other) (NNS means)) (SBAR (WHPP (IN through) (WHNP (WDT which))) (S (NP (JJ interested) (NNS actors)) (VP (VBP have) (VP (VBN sought) (S (VP (TO to) (VP (VB build) (NP (NP (NN capacity)) (PP (IN for) (NP (NP (NN research)) (PP (IN into) (NP (JJ rare) (JJ medical) (NNS conditions)))))))))))))))) (. .))
(S (PP (TO To) (NP (NN date))) (ADVP (RB however)) (NP (NP (JJ systematic) (JJ empirical) (NN evidence)) (SBAR (S (VP (TO to) (VP (VB compare) (NP (NP (DT the) (JJ relative) (NN importance)) (PP (IN of) (NP (JJ different) (NNS actors))) (PP (IN in) (S (VP (VBG funding) (NP (JJ rare) (NN disease) (NN research))))))))))) (VP (VBZ has) (RB not) (VP (VBN been) (VP (VBN produced)))) (. .))
(S (S (VP (VBG Building) (PP (IN on) (NP (NP (NN interest)) (PP (IN in) (NP (NP (NP (JJ undone) (NN science)) (PP (IN in) (NP (NNP STS)))) (CC and) (NP (NN science) (NN policy) (NNS studies)))))))) (, ,) (NP (PRP$ our) (NN study)) (VP (VBZ hopes) (S (VP (S (VP (TO to) (PRT (JJ map-out)) (NP (NP (NP (JJ different) (NNS kinds)) (PP (IN of) (NP (NN funding) (NNS actors)))) (CC and) (NP (NP (PRP$ their) (NN influence)) (PP (IN on) (NP (NP (VBG leading) (JJ scientific) (NN research)) (PP (IN on) (NP (JJ rare) (NNS diseases))))))) (, ,))) (PP (IN by) (NP (NP (NN use)) (PP (IN of) (NP (JJ bibliometric) (NNS tools)))))))) (. .))
(S (NP (NP (DT The) (NN approach)) (SBAR (S (NP (PRP we)) (VP (VBP are) (VP (VBG developing)))))) (VP (NNS relies) (PP (IN on) (NP (NP (DT the) (NN use)) (PP (IN of) (NP (NP (NNP Funding) (NNP Acknowledgement) (NNS data)) (VP (VBD provided) (PP (IN in) (NP (NAC (NNP Web) (PP (IN of) (NP (NNP Science)))) (NN database))))))))) (. .))
